Belize vs Libya: Cause of death, by non-communicable diseases, ages 15-59, female
Belize
61.7%
in 2021
Libya
60.9%
in 2021
Belize rank
92nd
Libya rank
95th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Belize
- Libya
How they compare
Belize currently reports 61.7% against 60.9% in Libya, a difference of 0.8%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Libya ahead.
Belize ranks 92nd and Libya ranks 95th of 185 countries.
Across the 3 decades both report, Belize averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Belize | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.3% | 68.5% | 8.2% | Libya |
| 2010s | 64.6% | 68.3% | 3.7% | Libya |
| 2020s | 63.2% | 62.9% | 0.3% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Belize or Libya?
- Belize, at 61.7% against 60.9% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Belize and Libya?
- 0.8%, with Belize ahead.
- How many years of comparable data are there for Belize and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Libya rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Belize ranks 92nd and Libya ranks 95th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.